3,6-Dichloropyridazine → HCID 86702082, 화합물
반응식
[NH:1]1[CH2:4][CH:3]([C:5]([NH:7][C:8]2[CH:13]=[CH:12][C:11]([CH:14]3[CH2:19][CH2:18][N:17]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:16][CH2:15]3)=[CH:10][CH:9]=2)=[O:6])[CH2:2]1.[F:27][C:28]1[N:29]=[N:30][C:31](F)=[CH:32][CH:33]=1.ClC1N=NC(Cl)=CC=1>>[F:27][C:28]1[N:29]=[N:30][C:31]([N:1]2[CH2:4][CH:3]([C:5]([NH:7][C:8]3[CH:13]=[CH:12][C:11]([CH:14]4[CH2:15][CH2:16][N:17]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:18][CH2:19]4)=[CH:10][CH:9]=3)=[O:6])[CH2:2]2)=[CH:32][CH:33]=1참가 물질
4
실험 절차
The title compound was prepared as described in Example 147A, substituting tert-butyl 4-(4-(azetidine-3-carboxamido)phenyl)piperidine-1-carboxylate for tert-butyl 4-(4-(azetidine-3-carboxamido)phenyl)piperidine-1-carboxylate and 3,6-difluoropyridazine for 3,6-dichloropyridazine.
출처 및 근거
- ORD 기록
- ord-3839948986cb41ffa2d667e71deb3992
- 출처 데이터셋
- uspto-grants-2015_03